The evolving role of interferons in viral eradication strategies

The evolving role of interferons in viral eradication strategies

Interferons (IFNs) are a family of pleiotropic cytokines that are released when viral infection is sensed by pattern recognition receptors. They induce an antiviral state in target cells through influencing the expression of hundreds of genes termed IFN-stimulated genes (ISGs), which interfere with...

Full description

Bibliographic Details
Main Author:	Tomas Doyle
Format:	Article
Language:	English
Published:	Elsevier 2016-04-01
Series:	Journal of Virus Eradication
Subjects:	interferons IFN HIV HCV HBV
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020304672

Similar Items

Natural Killer Cell Functional Dichotomy: a Feature of Chronic Viral Hepatitis ?
by: Mario Umberto Mondelli, et al.
Published: (2012-11-01)

Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis
by: Fei Wang, et al.
Published: (2023-12-01)

The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients
by: Claudia da Silva, et al.

Prevention of viral infection transmission in dental practice
by: Latković Marina
Published: (2014-01-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Interferon and interferon-stimulated genes in HBV treatment
by: Qirong Li, et al.
Published: (2022-12-01)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
by: Keeffe Emmet B, et al.
Published: (2005-09-01)

Iatrogenic Blood-borne Viral Infections in Refugee Children from War and Transition Zones
by: Paul N. Goldwater
Published: (2013-06-01)

The Role of Bcl-xL Protein in Viral Infections
by: Zbigniew Wyżewski, et al.
Published: (2021-02-01)

Estimating the Transmission Risks of Viral Hepatitis and HIV Among Blood Donors in Hossana, Southern Ethiopia
by: Beykaso G, et al.
Published: (2021-07-01)

A Study on the HBV and the HCV Infections in Female Sex Workers and their Co-Infection with HIV
by: Desai Praseeda S, et al.
Published: (2013-02-01)

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals
by: Vogel M, et al.
Published: (2010-03-01)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
by: Kamil Grubczak, et al.
Published: (2021-07-01)

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C
by: Patruno Savino FA, et al.
Published: (2002-08-01)

PREDICTORS OF SUSTAINED RESPONSE TO INTERFERON-BASED THERAPY IN CHRONIC HEPATITIS B
by: Deian Jelev, et al.
Published: (2011-10-01)

Mcl-1 Protein and Viral Infections: A Narrative Review
by: Zbigniew Wyżewski, et al.
Published: (2024-01-01)

Investigation of the Seroprevalence of Viral Hepatitis and Syphilis Coinfection in HIV Positive Cases
by: Mehmet ÇABALAK, et al.
Published: (2020-09-01)

The role of iron in viral infections
by: Sophie Marion Schmidt
Published: (2020-01-01)

THE IMPORTANCE OF ASSESSING INDICATORS OF LIPID METABOLISM IN CHRONIC VIRAL HEPATITIS
by: Tatiana Ghelmici, et al.
Published: (2023-08-01)

Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities
by: Micah Oyaro, et al.
Published: (2018-03-01)

Opportunistic infections among individuals with HIV-1/AIDS in the highly active antiretroviral therapy era at a Quaternary Level Care Teaching Hospital
by: Katia Jaira Galisteu, et al.
Published: (2015-04-01)

The seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus in patients undergoing septoplasty
by: Ozlem Onerci Celebi, et al.

Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002
by: Parivash Davoodian, et al.

Knowledge and attitude of dental students in Qazvin University of Medical Sciences about treatment of patients with HIV, HBV and HCV infections
by: F. Aghaei, et al.
Published: (2017-01-01)

TYPE I INTERFERON REGULATES THE EXPRESSION OF LONG NONCODING RNAs
by: Elena eCarnero, et al.
Published: (2014-11-01)

Multisite Performance Evaluation of the cobas 5800 System and Comparison to the cobas 6800/8800 Systems for Quantitative Measurement of HBV, HCV, and HIV-1 Viral Load
by: Jakob Tschäpe, et al.
Published: (2022-12-01)

Hepatitis B and C viral coinfections and their association with HIV viral load suppression among HIV-1 infected patients on ART at Mekelle hospital, northern Ethiopia
by: Gebrecherkos Teame, et al.
Published: (2022-12-01)

Retrospective Investigation of Viral Hepatitis Seroprevalence in Patients Admitted at the Outpatient Clinics of Internal Medicine
by: Hülya Duran, et al.
Published: (2023-05-01)

Forms and Methods for Interferon’s Encapsulation
by: Thelvia I. Ramos, et al.
Published: (2021-09-01)

ADAR1 Function Regulates Innate Immune Activation and Susceptibility to Viral Infections
by: Maria Pujantell, et al.
Published: (2020-06-01)

Viral Infection and Lung Cancer Immunotherapy
by: Ewa Kalinka, et al.
Published: (2021-08-01)

Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma
by: Mohamed A. Abdel Mohsen, et al.
Published: (2014-09-01)

Assisted Reproductive Technology and Obstetric Outcome in Couples when The Male Partner Has A Chronic Viral Disease
by: Irene Molina, et al.
Published: (2014-01-01)

Prevalence of hepatitis B and C viral co-infection and associated factors with HIV infection in children in South Kivu, Democratic Republic of the Congo
by: Serge Ahuka Miyanga, et al.
Published: (2023-08-01)

Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection
by: Anna Paola Carreca, et al.
Published: (2022-07-01)

Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice
by: Luisa Cavalletto, et al.
Published: (2008-01-01)

Frequency of viral infections in adolescent and adult in-patient Ethiopians with acute leukemia at presentation to a tertiary care teaching hospital: a cross-sectional study
by: Jemal Alemu, et al.
Published: (2023-07-01)

Anti-diabetic drugs, insulin and metformin, have no direct interaction with hepatitis C virus infection or anti-viral interferon response
by: Mohamad S. Hakim, et al.
Published: (2014-01-01)

Viral Hepatitis in Renal Transplant Patients
by: Bernieh Bassam, et al.
Published: (1999-01-01)

Seroprevalence and risk factors of HBV, HCV and HIV among hemodialysis patients: a multicenter cross-sectional study from Damascus Syria
by: Jehan Altinawe, et al.
Published: (2024-03-01)